Sthanu Subramanian/X
Apr 5, 2026, 16:16
Sthanu Subramanian։ Understanding Antiphospholipid Syndrome and Its Thrombotic Risks
Sthanu Subramanian, Pediatrician, shared a post on X:
”Antiphospholipid Syndrome (APS), also known as Hughes’ Syndrome, an autoimmune condition where the body produces abnormal antibodies (such as Lupus antibody, Anti-cardiolipin, and Anti-β2-glycoprotein 1) that attack cell membrane components.
This process increases the risk of dangerous blood clots in both arteries and veins.”
Stay updated with Hemostasis Today.
-
Jul 12, 2026, 16:15Louise St. Germain Bannon: Global Collaboration Is Key to Turning Scientific Innovation Into Better Care
-
Jul 12, 2026, 16:10Marc Carrier: Major Scientific Highlight Confirms the Safety of the YEARS Algorithm at ISTH 2026
-
Jul 12, 2026, 16:01Joseph R. Shaw: Sharing New Insights into Antithrombotic Therapy and Thrombin Generation at ISTH 2026
-
Jul 12, 2026, 15:45Nathan Connell: Key Clinical Advances in Heavy Menstrual Bleeding and Postpartum Hemorrhage from ISTH 2026
-
Jul 12, 2026, 15:40Anne-Claire Duchez: Join Us at ISTH 2026 to Discover Our Latest Research and Meet the Team
-
Jul 12, 2026, 12:30Reduced-Dose DOACs in GI Malignancies: Toward Personalized Anticoagulation
-
Jul 12, 2026, 08:50Where the Hemophilia Community Comes Together at ISTH 2026 – EAHAD
-
Jul 12, 2026, 08:2210 Posts Not To Miss from ISTH 2026, Part 1
-
Jul 12, 2026, 07:58Brian O Mahony: Could NXT-007 Minimize the Need for Perioperative FVIII